The project, operating under the acronym PAT (Psoriasis Anti-inflammatory Treatment), will involve other consortium partners Biopta, Midatech Biogune and the University Hospital Zurich. Telormedix raised funding from the European Eurostars Programme to coordinate this international research project for one of its promising drug candidates, TMX-302, which will use Midatech's glycan-coated gold nanoparticles formulated using Molecular Profiles' expertise.
The deal comes just weeks after Molecular Profiles announced the official opening of its new facility following a successful inspection from the Medical and Healthcare products Regulatory Agency (MHRA), and on the heels of its acquisition by
Molecular Profiles' chief executive officer
"We anticipate that this is just the start of a longer-term clinical development and manufacturing initiative to support a future trial. Beyond the formulation work, our new facility gives Telormedix the reassurance we can also support their finished dosage form production requirements."
Working with leading pharmaceutical companies across the globe, Molecular Profiles' specialises in advanced characterisation, pre-clinical and clinical development, clinical manufacturing and analytical support. Its early-stage services extend from pre-formulation, formulation development and solid-state screening with specialist knowledge on developing challenging molecules.
Its new clinical manufacturing facility enables the company to handle a range of dosage forms such as solids, liquids, semi-solids and inhaled products. Supporting clients' projects up to phase IIb, the company can manufacture controlled drugs and highly potent compounds up to OEB 4 level with batch scale of up to 30kg. www.molprofiles.co.uk/ | email@example.com | https://twitter.com/MolProfiles For further information, images and interview opportunities with Molecular Profiles, please contact
The Eurostars Programme is the European funding and support programme specifically dedicated to stimulating international collaborative research and innovation projects of small and medium enterprises. For further information on the Eurostars Programme, please visit: www.eurostars-eureka.eu About Telormedix Telormedix (www.telormedix.com), founded in
Keywords for this news article include: Drugs, Therapy, Psoriasis, Treatment, Dermatology, Dosage Forms, Biopharmaceuticals,
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2013, NewsRx LLC
Most Popular Stories
- AIG to Create 230 Jobs in Charlotte
- Bipartisan Negotiators Reach Modest Budget Agreement
- Russia Says Nyet to Canada North Pole Claim
- Justin Bieber Visits Typhoon Victims, Plays Concert
- Senate Dems Move Forward With Obama Nominees
- Obama Nominee Confirmed for D.C. Appeals Court
- New Obama Aide to Focus on Climate Change
- MasterCard to Split Shares, Raise Dividend
- GOP, Dems Strain to Unearth a Modest Budget Pact
- 15 Myths That Could Ruin Your Hispanic Ad Campaign